Health
FDA Approves New Cholesterol Medication
The FDA has approved the first daily pill to drastically lower cholesterol levels, rivaling existing powerful drugs. The new medication from Merck is expected to offer a more convenient treatment option for patients.
Coverage timeline — 1 article
The Hill
Federal regulators approved a first-of-its-kind cholesterol medication from Merck that rivals the effectiveness of powerful drugs already on the market. The Food and Drug Administration (FDA) greenlit the once-daily pill called Lipfendra. Lipfendra reduces “bad,” or low-density lipoprotein choleste
2026-07-16 18:56 UTC